Date: Tuesday, March 2, 2021
Time: 1-2 p.m.
Overdose deaths associated with illicit stimulants (cocaine and methamphetamine) have surged in the past eight years, according to a recent study by the National Institutes for Health (NIH). While there are currently no FDA-approved medications for the treatment of individuals who are dependent on stimulants, new treatments utilizing readily available medications are showing encouraging empirical support.
Join us Tuesday, March 2, at 1 p.m. ET, for “Medication Options for Treatment of Stimulant Use Disorders: Optimistic Update and New Research,” when we’ll examine the latest groundbreaking research in the context of current increases in stimulant use. Marc Fishman, MD, medical director of Maryland Treatment Centers, a member of the psychiatry faculty of the Johns Hopkins University School of Medicine, and a member of the National Council’s Medical Director Institute will share his expertise as an addiction medicine specialist to bring the latest information to help you:
Explore new research that provides evidence for the potential treatment of stimulant use disorder treatment.
Register HERE